On August 3, 2021, the Board of Directors (the “Board”) of the Company elected Susan Dodson DeVore to serve as an independent director effective immediately, with a term expiring at the Company’s 2022 annual meeting of shareholders.
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.95
Susan Dodson DeVore was elected as independent director at Elevance Health, Inc..
Action
elected
Role
independent director
Exact text from the filing
On August 3, 2021, the Board of Directors (the “Board”) of the Company elected Susan Dodson DeVore to serve as an independent director effective immediately, with a term expiring at the Company’s 2022 annual meeting of shareholders.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.